| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 07/11/2002 | WO2002053747A1 Process for producing prenyl alcohol |
| 07/11/2002 | WO2002053746A1 Process for producing prenyl alcohol |
| 07/11/2002 | WO2002053745A1 Process for producing prenyl alcohol |
| 07/11/2002 | WO2002053742A2 Proteins and nucleic acids encoding same |
| 07/11/2002 | WO2002053740A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 07/11/2002 | WO2002053738A1 Novel proteins and dnas thereof |
| 07/11/2002 | WO2002053737A1 Nf-kb activating gene |
| 07/11/2002 | WO2002053736A1 Method of examining ability to control nerve cell plasticity |
| 07/11/2002 | WO2002053735A1 Trasncription activation complex and utilization thereof |
| 07/11/2002 | WO2002053733A2 Regulation of human b7-h2 protein |
| 07/11/2002 | WO2002053730A1 Novel potassium channel |
| 07/11/2002 | WO2002053729A1 Bhlh-pas proteins, genes thereof and utilization of the same |
| 07/11/2002 | WO2002053728A2 Gene disruption methodologies for drug target discovery |
| 07/11/2002 | WO2002053727A1 Three dimensional structure of human derived apoptotic factor and receptor thereof by x-ray chrystallography and trail deletion mutant protein |
| 07/11/2002 | WO2002053724A2 Enzymatic deprotection of amines and hydroxides |
| 07/11/2002 | WO2002053717A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/11/2002 | WO2002053707A1 Microorganism producing l-lysine and processes for producing l-lysine using the same |
| 07/11/2002 | WO2002053706A1 Novel lactobacillus paracasei subsp. paracasei strain antibacterial against helicobacter pylori and escherichia coli 157:h7 |
| 07/11/2002 | WO2002053705A1 Culture medium for detecting bacteria of listeria genus |
| 07/11/2002 | WO2002053596A2 Antibodies to insulin-like growth factor i receptor |
| 07/11/2002 | WO2002053592A1 Novel polypeptide and dna thereof |
| 07/11/2002 | WO2002053588A2 Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of chlamydia psittaci |
| 07/11/2002 | WO2002053581A2 Spliceosome mediated rna trans-splicing |
| 07/11/2002 | WO2002053569A1 Method of assaying lysophospholipase d activity |
| 07/11/2002 | WO2002053180A2 Immunizing compositions and methods of use |
| 07/11/2002 | WO2002053163A1 Medicines for relieving intestinal disorders |
| 07/11/2002 | WO2002052936A1 Preserving agents for freeze-dried cells |
| 07/11/2002 | WO2002032288A3 Cd38 modulated chemotaxis |
| 07/11/2002 | WO2002022843A3 Nucleotide sequences which code for the dep34 gene |
| 07/11/2002 | WO2002022829A3 Nucleotide sequences which code for the ppsa gene |
| 07/11/2002 | WO2002020728A3 High growth methanotrophic bacterial strain methylomonas 16a |
| 07/11/2002 | WO2002016421A8 Altered ospa of borrelia burgdorferi |
| 07/11/2002 | WO2002014511A3 Regulation of human p2y1-like g protein-coupled receptor |
| 07/11/2002 | WO2002010199A3 C3b/c4b complement receptor-like molecules and uses thereof |
| 07/11/2002 | WO2002008286A3 Zinc finger domain recognition code and uses thereof |
| 07/11/2002 | WO2001096580A3 Method for modifying plant morphology, biochemistry and physiology using cytokinin oxidases |
| 07/11/2002 | WO2001094550A3 Identification and use of molecular markers indicating cellular reprogramming |
| 07/11/2002 | WO2001094548A3 Hy2 family of bilin reductases |
| 07/11/2002 | WO2001081412A3 Isolated human transporter proteins, nucleic acid molecules encoding the same, and uses thereof |
| 07/11/2002 | WO2001046443A3 Proteases |
| 07/11/2002 | WO2001044478A9 CORE 1 β3-GALACTOSYL TRANSFERASES AND METHODS OF USE THEREOF |
| 07/11/2002 | WO2001044473A3 Polypeptides and nucleic acids encoding same |
| 07/11/2002 | WO2001040476A3 Bacillus thuringiensis toxin active against formicidae (ant) |
| 07/11/2002 | WO2001025438A3 Ifn-alpha homologues |
| 07/11/2002 | WO2001019972A3 Fermentation process with immobilized microorganisms |
| 07/11/2002 | WO2001016322A3 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 07/11/2002 | WO2001010907A9 Therapeutic polypeptides and methods for using same |
| 07/11/2002 | WO2001010205A9 Methods and materials relating to cd39-like polypeptides |
| 07/11/2002 | WO2000073321A9 Human tumor necrosis factor receptor tr10 |
| 07/11/2002 | WO2000063438A3 Method of classifying a thyroid carcinoma using differential gene expression |
| 07/11/2002 | WO2000061747A9 Clasp-2 transmembrane proteins |
| 07/11/2002 | WO2000058472A9 Isolated dna encoding cullin regulators roc1 and roc2, isolated proteins encoded by the same, and methods utilizing the same |
| 07/11/2002 | US20020092040 DNA sequences coding for enzymes capable of facilitating the synthesis of linear alpha-1, 4 glucans in plants, fungi and microorganisms |
| 07/11/2002 | US20020091249 Human tumor suppressor polypeptides |
| 07/11/2002 | US20020091247 Polycyclic aromatic hydrocarbon induced molecules |
| 07/11/2002 | US20020091244 Nucleotide sequences for use in diagnosis and treatment of cancer and immunological disorders |
| 07/11/2002 | US20020091236 Nucleotide sequences coding preferential polypeptide for use in detection of bactericides |
| 07/11/2002 | US20020091096 Nucleic acid, including DNA, immunization against disease caused by infection by a strain of Chlamydia employing a vector, containing a nucleotide sequence encoding a lorf2 protein of a strain of Chlamydia |
| 07/11/2002 | US20020091084 Human calcineurin B-like protein (CAB) and polynucleotides which identify and encode CAB. |
| 07/11/2002 | US20020090715 Method for the preparation of a viral vector by inter-molecular homologous recombination |
| 07/11/2002 | US20020090713 Heat-stable D-aminoacylase |
| 07/11/2002 | US20020090709 Modifided carboxypeptidase enzymes and their use |
| 07/11/2002 | US20020090708 DNA encoding tumor necrosis factor stimulated gene 6 (TSG-6) |
| 07/11/2002 | US20020090703 Mammalian protein phosphatases |
| 07/11/2002 | US20020090700 Nucleotide sequences encoding the ptsH gene |
| 07/11/2002 | US20020090698 Recombinant process for the production in pseudomonas putida of the cytochrome c551 of pseudomonas aeruginosa |
| 07/11/2002 | US20020090695 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 07/11/2002 | US20020090694 Human Hox C10 and polynucleotides encoding |
| 07/11/2002 | US20020090693 Novel human sodium-dependent phosphate cotransporter |
| 07/11/2002 | US20020090689 Production of ascorbic acid |
| 07/11/2002 | US20020090688 Generating vitamin c in microorganism; obtain micoorganism, incubate in presence of carbon source, recover vitamin c |
| 07/11/2002 | US20020090685 Nucleotide sequences coding for the ndkA gene |
| 07/11/2002 | US20020090679 Lung growth factor variant |
| 07/11/2002 | US20020090635 Compositions and methods for the release of nucleic acid molecules from solid matrices |
| 07/11/2002 | US20020090376 Administering to the animal bacterial cells having a mutated poxR gene for inducing immune response in animal |
| 07/11/2002 | US20020090373 ADAMTS polypeptides, nucleic acids encoding them, and uses thereof |
| 07/11/2002 | US20020090365 For therapy of vaginal and gastrointestinal infections |
| 07/11/2002 | DE10063048A1 Einzelketten-Antikörper mit verbesserter Stabilität Single-chain antibody with improved stability |
| 07/11/2002 | DE10061864A1 Rekombinante Schweineleberesterase, deren Verwendung sowie ein Verfahren zu deren Herstellung Recombinant porcine liver esterase, to their use and to a process for their preparation |
| 07/11/2002 | CA2708949A1 Immunizing compositions and methods of use |
| 07/11/2002 | CA2689741A1 Latent human tuberculosis model, diagnostic antigens, and methods of use |
| 07/11/2002 | CA2434118A1 Spliceosome mediated rna trans-splicing |
| 07/11/2002 | CA2433800A1 Antibodies to insulin-like growth factor i receptor |
| 07/11/2002 | CA2433782A1 Proteins and nucleic acids encoding same |
| 07/11/2002 | CA2433628A1 Enzymatic deprotection of amines and hydroxides |
| 07/11/2002 | CA2433561A1 Compositions including gram negative siderophore receptor proteins and methods of use |
| 07/11/2002 | CA2433559A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/11/2002 | CA2433534A1 Process for producing prenyl alcohol |
| 07/11/2002 | CA2433529A1 Process for producing prenyl alcohol |
| 07/11/2002 | CA2433526A1 Process for producing prenyl alcohol |
| 07/11/2002 | CA2433492A1 Transcription activation complex comprising arnt 1 to 3 and a transcriptional regulatory factor and uses thereof |
| 07/11/2002 | CA2433430A1 Method for producing heterologous proteins in a homothallic fungus of the sordariaceae family |
| 07/11/2002 | CA2432902A1 Gene disruption methodologies for drug target discovery |
| 07/11/2002 | CA2432426A1 Recombinant protective protein from streptococcus pneumoniae |
| 07/11/2002 | CA2432339A1 Identification of the genetic determinants of the polymorphic cyp3a5 expression |
| 07/11/2002 | CA2430667A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 07/10/2002 | EP1221489A1 Regulatory sequences functioning in filamentous fungi |
| 07/10/2002 | EP1221484A2 Biosynthetic osteogenic proteins and osteogenic devices containing them |
| 07/10/2002 | EP1221482A1 Novel hemopoietin receptor protein, nr12 |
| 07/10/2002 | EP1221480A1 Polypeptide humanin inhibiting nerve cell death |